Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Power Metallic Mines uses muon tomography to map deep mineralization at Nisk project in Quebec

Market News
13 May 2026
Proactive Investors
View Source
Bullish
pluang ai news

Power Metallic Mines has partnered with Ideon Technologies to deploy borehole muon tomography at its Lion Zone within the Nisk polymetallic project in Quebec. This advanced imaging technology will create a 3D density model of the rock, helping to identify deeper mineral targets beyond 200 meters where traditional methods struggle. The program aims to validate the imaging against existing drill data and then apply the findings to guide further exploration across the 330-square-kilometer property. This approach could accelerate discovery of higher-quality ore as the company prepares to publish its first mineral resource estimate this summer.

More News

Quantum Cyber secures exclusive drone tech license amid $55B US drone warfare budget boost

Quantum Cyber secures exclusive drone tech license amid $55B US drone warfare budget boost

Quantum Cyber has secured an exclusive license for BP United's autonomous drone technology, including a sky defense platform capable of over 25 km range and fully autonomous operations. This move positions Quantum Cyber to capitalize on the Trump adm...

Market News
Bullish
52 minutes ago
Silexion starts GMP manufacturing of SIL204 and gets Phase 2/3 trial approval for pancreatic cancer.

Silexion starts GMP manufacturing of SIL204 and gets Phase 2/3 trial approval for pancreatic cancer.

Silexion Therapeutics has begun Good Manufacturing Practice (GMP) clinical batch production of SIL204, a next-generation siRNA therapy targeting mutated KRAS in pancreatic cancer. The Helsinki Ethics Committee at Tel Aviv Sourasky Medical Center appr...

Company Fundamentals
Bullish
52 minutes ago
Brown-Forman rejects $15B cash bid from Sazerac weeks after ending talks with Pernod Ricard.

Brown-Forman rejects $15B cash bid from Sazerac weeks after ending talks with Pernod Ricard.

Brown-Forman, maker of Jack Daniel's, has declined a $15 billion all-cash acquisition offer from competitor Sazerac, which valued the company at $32 per share. This rejection follows the recent end of merger discussions between Brown-Forman and Perno...

Company Fundamentals
Bearish
1 hour ago
Andera Partners leads $20M Series D to advance Rivermark's FloStent for BPH treatment.

Andera Partners leads $20M Series D to advance Rivermark's FloStent for BPH treatment.

Andera Partners led a $20 million Series D funding round for Rivermark Medical, supporting the development and upcoming commercial launch of the FloStent System, a non-surgical, reversible device for treating benign prostatic hyperplasia (BPH). The f...

Company Fundamentals
Bullish
1 hour ago
SYX-5219 shows safety and immune benefits in Phase 1a trial for atopic dermatitis treatment

SYX-5219 shows safety and immune benefits in Phase 1a trial for atopic dermatitis treatment

Sitryx Therapeutics announced positive Phase 1a trial results for SYX-5219, an oral PKM2 modulator targeting atopic dermatitis. The trial in healthy volunteers showed the drug was safe, well tolerated, and demonstrated immune system modulation by red...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App